{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:57:40Z","timestamp":1790495860005,"version":"4.1.0"},"reference-count":12,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Endovasc Ther"],"abstract":"\n Objective:<\/jats:title>\n The aim of this study was to evaluate outcomes of fenestrated-branched endovascular aortic repair (FB-EVAR) of thoracoabdominal aortic aneurysms (TAAAs) and complex abdominal aortic aneurysms (CAAAs) in patients actively smoking at the time of repair compared with previous smokers and non-smokers.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n Single-center retrospective review of elective FB-EVARs for TAAA and CAAAs between 2007 and 2023 was conducted. Demographics, comorbidities, aneurysm extent\/ morphology, technical details, and peri-operative outcomes were collected. Patients were grouped into 1 of 3 groups: active smokers, prior smokers, and never smokers. Patients who stopped smoking within 6 weeks to surgery were considered active smokers. Rupture and symptomatic aneurysms were excluded. Endpoints included early (<30 days) mortality and major adverse events (MAEs).<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n There were 676 patients (73% male, mean age 74\u2009\u00b1\u20097.8). There were 141 (21%) active smokers, 455 (67%) prior smokers, and 80 (12%) never smokers. Active smokers were significantly younger than prior or never smokers (71\u2009\u00b1\u20096.7, 75\u2009\u00b1\u20096.9, and 76\u2009\u00b1\u200912, respectively;\n P<\/jats:italic>\n \u2009<\u2009.001). Cardiovascular risk factors were similar, except active smokers were significantly more likely to have chronic obstructive pulmonary disease (60% vs 42% vs 6.2%,\n P<\/jats:italic>\n \u2009<\u2009.001) and peripheral arterial disease (31% vs 24% vs 10%,\n P<\/jats:italic>\n \u2009=\u2009.002) when compared to prior and never smokers, respectively. Patients who never smoked had significantly more extent II aneurysms (34%) than prior (18%) and active (15%) smokers,\n P<\/jats:italic>\n \u2009=\u2009.001. Univariable and multivariable logistic regression analyses showed no statistically significant associations between smoking status and any specific peri-operative adverse events following surgery.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n Active smoking status does not appear to affect peri-operative outcomes after FB-EVAR for complex aortic aneurysms. Although smoking cessation must be strongly encouraged, repair should not be delayed due to active smoking status.<\/jats:p>\n <\/jats:sec>\n \n Clinical Impact<\/jats:title>\n These data suggest that active smoking, in isolation, should not be considered a contraindication to elective FB-EVAR when anatomy is suitable and patients are otherswise optimized. This is particularly relevant for high-risk patients who may have limited alternative treatment options. Proceeding with FB-EVAR in active smokers does not appear to compromise early safety or procedural efficacy.<\/jats:p>\n <\/jats:sec>","DOI":"10.1177\/15266028261484740","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:26:32Z","timestamp":1790130392000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Active Smoking in Peri-operative Outcomes of Patients Undergoing FB-EVAR for Thoracoabdominal and Complex Abdominal Aortic Aneurysms"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3132-541X","authenticated-orcid":false,"given":"Diego V. S.","family":"Rodrigues","sequence":"first","affiliation":[{"name":"Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T.","family":"Rogers","sequence":"additional","affiliation":[{"name":"Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4755-2596","authenticated-orcid":false,"given":"Jesse","family":"Chait","sequence":"additional","affiliation":[{"name":"Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Tabiei","sequence":"additional","affiliation":[{"name":"Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall R.","family":"DeMartino","sequence":"additional","affiliation":[{"name":"Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8953-7514","authenticated-orcid":false,"given":"Gustavo S.","family":"Oderich","sequence":"additional","affiliation":[{"name":"Division of Vascular and Endovascular Surgery, University of Texas in Houston, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo C.","family":"Mendes","sequence":"additional","affiliation":[{"name":"Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2022.07.027"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2020.06.011"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61602-X"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1177\/000331970305400501"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3181889d0d"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13019-017-0614-4"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2019.02.028"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198404000-00022"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1177\/1526602816648455"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2004.01.007"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2024.01.079"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2011.12.018"}],"container-title":["Journal of Endovascular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15266028261484740","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/15266028261484740","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15266028261484740","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:18:41Z","timestamp":1790493521000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/15266028261484740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":12,"alternative-id":["10.1177\/15266028261484740"],"URL":"https:\/\/doi.org\/10.1177\/15266028261484740","relation":{},"ISSN":["1526-6028","1545-1550"],"issn-type":[{"value":"1526-6028","type":"print"},{"value":"1545-1550","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"article-number":"15266028261484740"}}